Drug reps will promote Avandia (rosiglitazone) as more effective than metformin for initial therapy of type 2 diabetes

Drug reps will promote Avandia (rosiglitazone) as more effective than metformin for initial therapy of type 2 diabetes.

They're citing a new study that suggests patients maintain control longer with rosiglitazone than with metformin or glyburide.

You'll hear that 5-year treatment failures are 32% higher with metformin and 63% higher with glyburide compared to rosiglitazone.